Sturge-weber Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2016-05-05
Clinical Trial Update: Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS) [Phase 2]
A Phase 2 trial investigating adjunctive everolimus (RAD-001) for epilepsy in children with Sturge-Weber syndrome has been withdrawn.